The forecasted import of blood-grouping reagents to India shows a steady growth from 2024 to 2028, starting at $8.832 million in 2024 and reaching $10.238 million by 2028. This represents a compound annual growth rate (CAGR) of approximately 3.7% over the five-year period. Year-on-year analysis indicates a consistent upward trend with increases of 4.1% from 2024 to 2025, 3.9% from 2025 to 2026, 3.6% from 2026 to 2027, and 3.4% from 2027 to 2028. In 2023, the import value stood at a lower baseline, indicating strong growth as the market expands.
Future trends to watch for include:
- Technological advancements in blood-grouping reagents that may affect import volumes and values.
- Policy changes or trade agreements influencing the cost and availability of imports.
- Increased demand due to healthcare advancements and the expansion of medical facilities in India.
- Potential competition from domestic production as India looks to strengthen its local manufacturing capabilities.
